数据链接：
官方服务：
资源简介：
Donor factors for graft endothelium attenuation.
应用场景：
创建时间：
2022-04-05
相关数据集
How an ABO-incompatible graft may improve its survival by phenotype-specific glycosylation of the host. A hypothesis.
In contrast to non-nucleated ABO-incompatible red cells, which from a HLA-compatible donor are transfused to a blood group O(H) recipient and undergo immediate destruction, a nucleated, metabolic acti
DataCite Commons2020-09-04 更新90
How an ABO-incomcatible graft may survive by phenotype-specific glycosylation of the host. A hypothesis.
In contrast to non-nucleated ABO-incompatible red cells, which are transfused to a blood group O(H) recipient and undergo immediate destruction, a nucleated, metabolic active tissue that from the same
DataCite Commons2020-09-04 更新60
KEGG pathway analysis of the targets of the differentially expressed miRNAs in allografts/syngrafts.
KEGG pathway analysis of the targets of the differentially expressed miRNAs in allografts/syngrafts.
NIAID Data Ecosystem40
How an ABO-incomcatible graft may survive by phenotype-specific glycosylation of the host. A hypothesis.
In contrast to non-nucleated ABO-incompatible red cells, which are transfused to a blood group O(H) recipient and undergo immediate destruction, a nucleated ABO-incompatible, metabolic active tissue t
DataCite Commons2020-09-04 更新70
How an ABO-incompatible graft may contribute to its survival by phenotype-specific glycosylation of the host. A hypothesis.
In comparison with non-nucleated ABO-incompatible red cells, which undergo immediate destruction when transfused to a blood group O(H) recipient, a nucleated, metabolically active tissue transplanted
DataCite Commons2020-09-04 更新50
